{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["41"],"submitter":["Iacovino ML"],"funding":["Ministero della Salute"],"pubmed_abstract":["<h4>Background</h4>Generalizability of registrative clinical trials to real-world clinical practice is influenced by comparability of patients in the two settings. We compared characteristics of cancer patients in registrative trials with real-world clinical practice in Italy.<h4>Methods</h4>Data on age, sex and performance status (PS) were derived from web-based monitoring registries developed by Italian Medicines Agency (AIFA) and corresponding registrative trials reported in the European Public Assessment Reports (EPAR) of European Medicines Agency (EMA). Weighted means were calculated in registries and trials and differences were described. Multivariate analysis was performed using Principal Component Analysis and Cluster Analysis.<h4>Findings</h4>From January, 2013 to April, 2023, 419"],"journal":["The Lancet regional health. Europe"],"pagination":["100912"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC11041834"],"repository":["biostudies-literature"],"pubmed_title":["Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study."],"pmcid":["PMC11041834"],"pubmed_authors":["Perrone F","Salerno F","Cavanna L","Celant S","Blasi L","Olimpieri PP","Russo P","Cinieri S","Pinto C","Piccirillo MC","Iacovino ML","Canciello A","Sferrazza A","Beretta GD","Arenare L","Caglio A","Tomassini L","Di Segni S","Di Maio M"],"additional_accession":[]},"is_claimable":false,"name":"Comparison of baseline patient characteristics in Italian oncology drug monitoring registries and clinical trials: a real-world cross-sectional study.","description":"<h4>Background</h4>Generalizability of registrative clinical trials to real-world clinical practice is influenced by comparability of patients in the two settings. We compared characteristics of cancer patients in registrative trials with real-world clinical practice in Italy.<h4>Methods</h4>Data on age, sex and performance status (PS) were derived from web-based monitoring registries developed by Italian Medicines Agency (AIFA) and corresponding registrative trials reported in the European Public Assessment Reports (EPAR) of European Medicines Agency (EMA). Weighted means were calculated in registries and trials and differences were described. Multivariate analysis was performed using Principal Component Analysis and Cluster Analysis.<h4>Findings</h4>From January, 2013 to April, 2023, 419","dates":{"release":"2024-01-01T00:00:00Z","publication":"2024 Jun","modification":"2026-06-01T09:18:05.473Z","creation":"2026-04-08T11:08:15.412Z"},"accession":"S-EPMC11041834","cross_references":{"pubmed":["38665620"],"doi":["10.1016/j.lanepe.2024.100912"]}}